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The connective tissue stroma of malignant tumors is 
a newly formed tissue that supports the growth and 
progression of neoplastic cells. Proteoglycans are in- 
trinsic components of this complex structure and mo- 
lecular changes in this class of macromolecules can 
significantly affect behavioral properties of trans- 
formed cells. We report that human colon carcinoma 
contained increased levels of a chondroitin sulfate pro- 
teoglycan that exhibited an altered glycosaminoglycan 
structure in which 0- and 6-sulfated units, as detected 
by specific monoclonal antibodies, predominated. Pro- 
teoglycans with such epitopes were localized primarily 
to the connective tissue stroma surrounding the tumor 
cells but not to the tumor cells themselves or the native, 
non-cancerous connective tissue. Analysis of mRNA 
encoding PG-40, the main chondroitin sulfate proteo- 
glycan of colon tissue, revealed a 7-fold increase in the 
two transcripts encoding this gene product. This in- 
crease was evident whether the data were normalized 
to total RNA content or &actin mRNA levels. The 
altered steady state levels of PG-40 mRNA did not 
correlate with any significant gene amplification or 
rearrangement of PG-40 in human colon cancer. How- 
ever, when genomic DNA was tested for degree of 
methylation, the colon carcinoma tissue showed a 
marked hypomethylation of PG-40 gene locus, a find- 
ing that has been associated with increased gene acti- 
vation. Interestingly, PG-40 gene was also hypometh- 
ylated in cultured colon fibroblasts, which express PG- 
40, but not in colon carcinoma cells which do not 
express this gene. These results indicate that specific 
proteoglycan changes occur in colon carcinoma and 
that these alterations are the product of stromal cells 
that are topologically associated with and functionally 
respondent to the growing malignant cells. This is the 
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first evidence that enhanced PG-40 expression in a 
human malignant tissue is associated with a hypometh- 
ylated gene and suggests that the control of PG-40 
gene expression may represent an important factor in 
the progression of colon carcinoma. 
The degree of local tissue invasion by colorectal cancer, the 
second most common cancer in the western industrialized 
societies, is directly correlated with the clinical outcome (1). 
In the vast majority of cases, the invasion of the colonic wall 
is preceeded by an exophytic growth of neoplastic cells and 
stromal elements within the intestinal lumen (2). It is note- 
worthy that about half of the neoplastic mass is composed of 
stromal elements, primarily fibroblasts, smooth muscle, and 
endothelial cells, which together provide the necessary re- 
quirements for tumor growth and progression (3). Proteogly- 
cans are intrinsic constituents of this newly formed connec- 
tive tissue; and, particularly because of their complex poly- 
anionic nature, they have been implicated in a number of 
biological processes. Proteoglycans form a molecular sieve, 
are responsible for retaining water, act as growth promoting 
agents, operate as receptors for matrix molecules, and influ- 
ence the attachment and migration of cells along defined 
routes (4-7). It is conceivable, therefore, that the newly syn- 
thesized proteoglycan-enriched milieu that accompanies colon 
carcinoma can enhance the proliferation of this specific tumor 
by providing a favorable growth environment. 
The main hypothesis of our research is that the structure 
and formation of the tumor matrix is under the direct control 
of the neoplastic cells and, through a feedback loop, altered 
proteoglycan composition can influence the behavior of tumor 
cells. This hypothesis is based in part on our observation that 
human colon carcinomas have elevated amounts of a struc- 
turally altered chondroitin sulfate that results from the ab- 
normal production of these molecules by the connective tissue 
surrounding the neoplastic cells (8, 9). These changes could 
be partly reproduced in vitro using either tumor metabolites 
(10) or co-cultures of colon carcinoma and normal mesenchy- 
ma1 cells derived from human colon (11). 
We have now extended these studies using immunological 
and molecular biological probes specific for chondroitin sul- 
fate proteoglycan. The results indicate that previously unde- 
tected qualitative and quantitative changes in this gene prod- 
uct exist and further suggest that the aberrant expression of 
this proteoglycan occurs solely in connective tissue closely 
associated with neoplastic cells. We further show for the first 
time that enhanced expression of PG-40, determined by West- 
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11390 Altered Proteoglycan Expression in Colon Cancer 
ern and Northern blotting, is associated with hypomethyla- 
tion of PG-40 gene locus, a DNA change known to be directly 
linked to gene activation. Our results raise the novel possibil- 
ity that neoplastic-induced demethylating events may affect 
specific proteoglycan genes and offer a molecular explanation 
for the previously reported proteoglycan alterations in this 
human neoplasm. 
EXPERIMENTAL PROCEDURES 
Tissue Preparation and Proteoglycan Extraction-Colectomy spec- 
imens, obtained immediately after surgery, were opened longitudi- 
nally, the surface was gently washed with isotonic saline, and samples 
were taken from tumor and normal appearing mucosa. In all cases, 
the diagnosis of adenocarcinoma was made using endoscopic biopsy 
prior to resection. The samples were quickly frozen in liquid nitrogen 
and then transfered to a -75 “C freezer. A total number of 23 normal 
colon and 24 colon carcinoma samples were studied. In addition, a 
benign colonic polyp, human colon fibroblasts, and colon carcinoma 
(10) cells were studied. The number of normal and neoplastic tissue 
samples studied by various methodologies is indicated under “Re- 
sults.” For proteoglycan analysis, tissue aliquots (100-500 mg) were 
homogenized in 4 M guanidine HCl, 0.5 M sodium sulfate, pH 5.8, 
containing 0.1 M NaCl, 2% Triton X-100 and various protease inhib- 
itors (12). Aliquots of [YS]sulfate-labeled heparan sulfate proteogly- 
can isolated from human colon carcinoma cells (12) were added to 
monitor recovery during the subsequent purification steps. Samples 
were cleared by centrifugation a 10,000 X g for 1 h at 4 “C and purified 
by sequential Sephadex G-50 and DEAESephacel(l2). Recovery of 
the radiolabeled carrier proteoglycan exceeded 90%. 
MultLple Western Blotting-Agarose-acrylamide gel electrophore- 
sis, trans-blotting to nitrocellulose, multiple immunoblotting, and 
subsequent visualization with ‘Z51-labeled secondary antibodies was 
done as described (13). This technique has the advantage of analyzing 
small samples of tissue with quantitative recovery and permanent 
trans-blot that can be probed with various antibodies before and after 
enzymatic removal of glycosaminoglycans (13). The following mono- 
clonal antibodies were used: (i) CS-56, directed against native chon- 
droitin sulfate (14); (ii) 2B6, directed against chondroitin 4-/dermatan 
sulfate (15); (iii) 3B3, directed against chondroitin 6-sulfate (15); (iv) 
lB5, directed against chondroitin O-sulfate (15), and (v) 7D4 and 6C3, 
directed against native/oversulfated chondroitin sulfate (16, 17). In 
addition, we used a monospecific antibody raised against the amino 
terminal peptide of PG-40 (18). Multiple immunoblotting was made 
possible through removal of antibodies with 3 M sodium thiocyanate, 
0.5% 2+mercaptoethanol, 0.5% Tween 20, pH 9.5. The exposure of 
the trans-blots to this chaotropic solution appears to have no effect 
on the immobilized proteoglycans (13). To visualize unsaturated A 
4,5 glcAgalNAc O-SOS, 4-SO*, or 6-SO, residues attached to the 
protein core, the membranes were immersed in 0.05 units of protease- 
free chondroitinase ABC in 10 ml of 0.2 M Tris buffer, pH 8.0, for 18 
h at 37 “C. As shown before (13), the deglycosylated proteoglycans 
are totally retained in the membrane and can react with specific 
antibodies. Autoradiographs were quantified in a laser beam scanning 
densitometer (LKB Instruments) by comparing the area under a scan 
to that of a 250-ng bovine nasal cartilage standard, an AlDl prepa- 
ration containing 70 ng of uranic acid. This amount of standard was 
well within the range of a linear relationship between concentration 
and absorbance. The calculated amounts of proteoglycan are therefore 
estimates based on the content of epitopes, reactive with the various 
antibodies, as found in bovine nasal cartilage. 
Zmmunohistochemical Studies-To investigate the tissue expres- 
sion and localization of chondroitin sulfate proteoglycan in human 
colon and colon carcinoma, the monoclonal antibodies described 
above were tested on both deparaffinized formaldehyde-fixed or fro- 
zen sections. Immunoperoxidase staining before and after chondroi- 
tinase ABC digestion &as performed as described (15-17). 
RNA Isolation, Northern, and Slot Blotting-Total RNA was pre- 
pared from frozen tissue pulverized under liquid nitrogen according 
to the acid guanidinium thiocyanate method (19) with the addition 
of 10.5 mM vanadyl ribonucleoside complex (Bethesda Research 
Laboratories). RNA was also isolated from human colon fibroblasts, 
colon smooth muscle, and carcinoma cells using 6-8 T-150 Falcon 
flasks (2-5 X 10’ cells/flask) each. Poly(A+) RNA was purified on 
oligo(dT)-cellulose columns (ZO), separated by electrophoresis in 1% 
formaldehyde-agarose gels (21), and transferred to nylon membranes 
(Hybond, Amersham Corp.). Denatured RNA samples were analyzed 
by slot blot using a Minifold II apparatus (Schleicher and Schull) 
and BA85 nitrocellulose paper. Both nylon and nitrocellulose mem- 
branes were treated at 89°C for 2 h under vacuum before prehybrid- 
ization and hvbridization with a full-lenath 1.8-kb’ PG-40 cDNA. 
The insert was excised by EcoRI digestion,ieparated on 1.2% agarose 
gel from the plasmid, purified by-GeneClean (Bio 101, San Diego, 
CA), and nick-translated using [a’P]dCTP to reach a specific activity 
>lOs cpm/pg DNA (22). To determine more exactly the amount of 
poly(A+) RNA, the slot blots were hybridized with a full-length 2.1- 
kb cDNA encoding human &actin (23). All the membranes were 
prehybrized at 65 ‘C for at least 5 h in 6 x SSC (1 X SSC = 0.15 M 
NaCl, 15 mM sodium citrate, pH 7.0), containing 1 X Denhardt’s 
solution, 0.1% sodium dodecyl sulfate, and 100 pg/ml salmon sperm 
DNA, and then hybridized with 32P-labeled probe for 18 h at 65 ‘C. 
The membranes were washed in 2 X, 1 X, and 0.5 X SSC for 30 min 
each and subjected to autoradiography using intensifying screens at 
-75 “C. After various exposures, autoradiograms were quantified by 
densitometry as described above. 
DNA Isolation and Southern Blotting-High molecular weight 
genomic DNA was prepared from 200 to 360 mg of tissue or from two 
to four T-150 flasks of confluent cells as described (24). Because of 
the intrinsic error in the solubilization of concentrated DNA solu- 
tions, equal amounts of DNA were initially digested with restriction 
enzymes as indicated below and run on 0.8% agarose gels in the 
presence of ethidium bromide (21). The gels containing digested and 
undigested samples were then photographed and each negative 
scanned. The results showed that the ratio of arbitrary absorbance 
units, determined by densitometry of the negatives, to that initially 
determined by spectrophotometry of DNA in solution was relatively 
constant with S.E. of 27% (n = 8). In a tvpical experiment, 20 erg of 
DNA were digested with PstI, BgZII, and-ZZindIII restriction endo- 
nucleases (5 unitslue DNA each) for 12 h at 37 “C, separated in 0.8% 
I .  1  _  
agarose gels, and blotted onto nitrocellulose (25). The blots were 
hybridized under high stringency to the PG-40 cDNA or to a full- 
length cDNA encoding the human C-WC proto-oncogene (26). To 
determine the degree of methylation of PG-40, DNA was digested 
with Z&a11 or MspI. HpaII cleaves 5’-CCGG-‘3 sequences only if the 
internal C is unmethylated (27), whereas MspI cleaves 5’-CCGG-3’ 
sequences regardless of C methylation (28). In addition, the Southern 
blots of HpaII- and &&I-digested DNA were hybridized with @-actin 
cDNA. 
RESULTS 
Proteoglycan Analysis and Western Blotting-Western blot 
analyses of DEAE-Sephacel-purified proteoglycans using well 
characterized monoclonal antibodies against intact chondroi- 
tin sulfate (14) or distinct isomers (15-17) revealed a marked 
increase in chondroitin sulfate in the malignant tissue (Fig. 
1, A and B). In both normal (Fig. IA, lanes 24) and tumor 
tissue (Fig. lA, lane 5), one broad band of chondroitin sulfate 
proteoglycan was detected by monoclonal antibody CS-56, a 
probe directed against intact chondroitin 4- or 6-sulfate chains 
(14). When the CS-56-reacted trans-blots were quantified by 
laserbeam densitometry (Fig. lB), a 3-fold increase in chon- 
droitin sulfate was detected in the tumor. 
Following chondroitinase ABC digestion, an enzymatic deg- 
radation that unmasks the three major isomeric epitopes of 
chondroitin sulfate attached to the protein core (8), significant 
qualitative and quantitative changes were further detected. 
By inspecting the autoradiographs (Fig. IA, lanes 16-18) it is 
evident that colon carcinoma tissue had a higher concentra- 
tion of epitopes reactive with monoclonal antibody 3B3 di- 
rected against the chondroitin B-sulfate isomer than the nor- 
mal colon tissue (Fig. IA, lanes 13-15). A similar increase in 
epitope reactivity of tumor tissue proteoglycan was also ob- 
served with monoclonal antibody lB5 that reacts with chon- 
droitin O-sulfate epitopes (not shown). In contrast, the relative 
amount of chondroitin 4-/dermatan sulfate, an epitope de- 
tected by monoclonal antibody 2B6, was not appreciably 
changed (Fig. IA, lanes 6-11). This major product was im- 
’ The abbreviation used is: kb, kilobase pair(s). 
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0 = Normal 
E&Q = Tumor 
4-S 6-S o-s 
Chondroitin Sulfate Chandroitin Sulfate Epitopes 
FIG. 1. Immunochemical analysis of proteoglycans in tissue 
extracts of normal human colon and colon carcinoma. Western 
blotting (A) of bovine nasal cartilage proteoglycan (BC), normal 
human colon (N), and colon carcinoma tissue (7’) using monoclonal 
antibodies against native chondroitin sulfate chains (lanes I-5), chon- 
droitin 4-/dermatan sulfate epitopes (lanes 6-22), or against chon- 
droitin B-sulfate epitopes (lanes 13-19). In order to visualize the 
chondroitin sulfate epitopes, the trans-blots were subjected to chon- 
droitinase ABC (protease-free) digestion before antibody reaction (A, 
lanes 6-19). Thus, lanes 6-19 represent chondroitin sulfate epitopes 
covalently attached to the protein core which is immobilized into the 
nitrocellulose membrane. B and C represent quantification of the 
autoradiograms by laserbeam densitometry as related to the concen- 
tration of uranic acid (28% of weight) in the standard cartilage 
proteoglycan run in parallel. 
munologically related to PG-40, since it was visualized by the 
antibody raised against the PG-40 protein core (not shown). 
A minor faster moving band was evidenced following a longer 
exposure. Both bands, however, were reactive with anti-PG- 
40 antibody (not shown), indicating that the two species 
varied in their degree of glycosylation. When the chondroiti- 
nase ABC-treated trans-blots were quantified by laserbeam 
densitometry, the relative amount of chondroitin 6-sulfate 
epitope and O-sulfate epitope was increased 6.3- and 3-fold 
(Fig. lC), respectively. Taken together, these results indicate 
that colon carcinoma tissue contains elevated amounts of a 
proteoglycan which is structurally and immunologically re- 
lated to PG-40, but with increased relative content of chon- 
droitin 6- and O-sulfate epitopes. 
Immunohistochemical Studies-We next examined the im- 
munohistochemical distribution of native protein-bound 
chondroitin sulfate chains (14), the three major chondroitin 
sulfate isomers (15-17), or the PG-40 protein core (18). Both 
normal and neoplastic epithelia were unreactive with all the 
anti-chondroitin sulfate proteoglycan antibodies (Fig. 2), in- 
dicating that these epithelial cells express little or no chon- 
droitin sulfate. In contrast, the connective tissue of normal 
and malignant colon expressed various degrees of immuno- 
reactivity with all the antibodies tested. Strikingly, the tissue 
distribution of the chondroitin g-sulfate epitope (Fig. 2, B and 
C) was markedly different from that of the chondroitin 4-/ 
dermatan sulfate epitope (Fig. 2, E-G). Whereas the latter 
epitope was present in both normal and malignant stroma at 
approximately equal intensities (Fig. 2, E-G), the chondroitin 
6-sulfate epitope was present almost exclusively in the con- 
nective tissue intimately associated with the malignant cells 
(Fig. 2B). The tumor stroma, although morphologically indis- 
tinguishable from native connective tissue (Fig. 2A), could be 
clearly separated from the pre-existing stroma by the high 
concentration of chondroitin 6-sulfate epitopes (Fig. 2B, UF- 
rowheads). A similar distribution was also observed for the 
chondroitin O-sulfate epitope (not shown) and the PG-40 
protein core epitope (Fig. 2K). Two other monoclonal anti- 
bodies, 7D4 and 6C3, which are comparable with the CS-56 
in that they recognize native chondroitin sulfate chains (16, 
17), exhibited a distribution similar to that of chondroitin 
4-/dermatan sulfate (Fig. 2, H-0. A summary of the immu- 
nohistochemical data is presented in Table I. These results 
indicate that the changes detected biochemically can be di- 
rectly correlated with an increased deposition of chondroitin 
6-sulfate and O-sulfate in the tumor-associated stroma. 
Analysis of RNA, Northern, and Slot Blotting-We next 
examined whether the steady state levels of mRNA encoding 
PG-40 protein core were altered in human colon carcinoma. 
First, quantification of total RNA extracted from normal and 
tumor tissue showed a reproducible 2.5-fold increase in total 
RNA in colon carcinoma (Fig. 3A). When equal amounts of 
poly(A+) RNA were analyzed by Northern blotting (Fig. 3B), 
the two major transcripts of 1.9 and 1.6 kb typical of PG-40 
(18) were observed in both normal and tumor samples. It was 
evident, however, that the amount of PG-40 transcripts was 
markedly increased in the tumor (Fig. 3B, lane 2) as compared 
with normal colon (Fig. 3B, lane 3). Similar transcripts were 
also observed in several mesenchymal cells including skin 
fibroblasts (Fig. 3B, lane 1), colon fibroblasts, and smooth 
muscle cells (not shown), but were not detected in WiDr colon 
carcinoma cells, a cell line that does not express this gene 
product (12). These findings are consistent with the notion 
that PG-40 is a product expressed primarily by connective 
tissue cells (7) and are in close agreement with the immuno- 
histochemical data presented above. 
Relative PG-40 transcript levels were measured by slot blot 
hybridization of RNA run in triplicate and further quantified 
by laserbeam densitometry and computer integration. The 
amount of specific PG-40 mRNA was increased nearly 3-fold 
in the tumor tissue uis 6. uis the normal colon tissue when 
normalized on a milligram of total RNA (Fig. 3C). However, 
when the values were corrected for changes in total RNA 
content (Fig. 3A) and expressed as relative hybridization/g of 
tissue (Fig. 30), there was a 7.4-fold increase in this transcript 
in the tumor. Normalization of the PG-40 mRNA levels to 
human p-actin mRNA levels showed similar PG-40 mRNA 
increases in colon carcinoma tissue, since @actin mRNA 
levels were not significantly different from those of normal 
colon (not shown). 
These results indicate that the increase in chondroitin 
sulfate proteoglycan detected biochemically and immunohis- 
tochemically is associated with elevated steady state levels of 
PG-40 mRNA. 
Analysis of DNA and Southern Blotting-To investigate 
further the molecular basis for the changes in PG-40 mRNA 
levels described above, we purified genomic DNA from sam- 
ples of normal colon (n = 6) and colon carcinoma (n = 8) 
tissue and determined the relative amounts by scanning ethid- 
ium bromide-stained agarose gels. In contrast to the RNA 
content, the total amount of DNA did not significantly vary 
between normal and tumor tissue (2.6-2.8 mg/g tissue). 
Therefore, the changes reported for mRNA are equally sig- 
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Altered Proteoglycan Expressior Colon Cancer 
FIG. 2. Gallery of light micrographs of human colon and colon carcinoma immunostained with 
antibodies to various epitopes of chondroitin sulfate proteoglycan. A, colon carcinoma tissue stained with 
hematoxylin and eosin. B, a sequential section from the same block stained with 3B3 monoclonal antibody directed 
against chondroitin 6-sulfate epitope; note the marked labeling of the tumor stroma by this antibody and the clear 
demarcation (arrowheads) from the native connective tissue; the malignant cells (asterisk) are totally unreactive. 
C, cross-section of normal colonic mucosa reacted with 3B3 monoclonal antibodies. D, control section in which 
the specific antibody was omitted. E, vertical section of normal colon reacted with 2B6 monoclonal directed against 
chondroitin 4-/dermatan sulfate epitopes; note the delicate distribution of this epitope in the interstitium of the 
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Altered Proteoglycan Expression in Colon Cancer 11393 
TABLE I 
Distribution of immunoreactive chondroitin sulfate epitopes in the stroma of normal and malignant human colon 
tissue 
The values represent a semiquantitative distribution of chondroitin sulfate proteoglycan epitopes in the stroma 
of normal human colon and colon carcinoma specimens. The relative intensity of immunostaining ranges from 
very strong (ii++), to weak (k), to undetectable (-). A total of 23 normal and 24 tumor samples were analyzed 
immunohistochemically. The first five monoclonal antibodies listed below recognize either specific disaccharide 
stubs remaining on the protein core following digestion with chondroitinase ABC (2B6, 3B3, and lB5) or the 
native chondroitin sulfate chains covalently linked to the protein core (7D4 and 6C3). The anti-PG-40 antibody is 
a monospecific rabbit anti-peptide antibody generated against eighteen amino acid comprising the amino terminus 
of PG-40/decorin protein core, a region that also contains the glycosaminoglycan binding domain (18). For 
additional details, see Fig. 2. 
Normal 
Antibody Epitope Malignant peritumorous 
Mucosa Submucosa stroma 
2B6 Chondroitin 4S/Dermatan sulfate 
3B3 Chondroitin 6-S 
lB5 Chondroitin O-S 
7D4 Native chondroitin sulfate 
6C3 Native chondroitin sulfate 
PG-40 PG-40 urotein core, “decorin” 
+ ++ +++ 
f - ++++ 
+ f ++++ 
++ + +++ 
++ ++ +++ 
+ ++ ++++ 
nificant when normalized to total DNA content. 
Genomic DNA was examined by Southern blot hybridiza- 
tion following digestion with PatI, BglII, and Hind111 restric- 
tion endonucleases. Both the pattern and relative intensity of 
PG-40 hybridization was similar in normal and tumor tissue 
(Fig. 4A), indicating that there was no gross genomic altera- 
tion for the PG-40 locus in this human tumor, i.e. no signifi- 
cant chromosomal rearrangement or gene amplification. A 
relatively limited number of fragments (two to five) were 
detected by PG-40 cDNA probe (Fig. 4A). These results are 
similar to those obtained using the same restriction endonu- 
cleases on human placental DNA (18) and suggest that not 
more than one or two genes encode PG-40. 
As a further control for the integrity of the purified DNA 
and for the hybridization data described above, we examined 
Southern blots of parallel DNA digests using a full-length 
cDNA encoding c-src proto-oncogene, a gene expressed by 
variety of tissues (26). The c-src probe reacted intensely with 
two major DNA fragments only in the P&I-digested DNA 
(Fig. 4B). The pattern and relative intensity of the hybridi- 
zation were similar in normal and tumor tissue (Fig. 4B), 
indicating no significant genomic alteration in the c-src and 
further validating the hybridization with PG-40 probe de- 
scribed above. 
Hypomethylation of PG-40 Gene in Colon Cancer-It has 
been shown that gene activation is associated with a decrease 
in DNA methylation, a covalent modification of the mam- 
malian genome that occurs almost exclusively at the dinucle- 
otide CG (29-31). Here we wanted to test whether PG-40 was 
indeed activated via a decrease in methylation and determine 
whether DNA from actively growing colon fibroblasts and 
colon carcinoma cells showed similar changes. To test these 
possibilities we used two methylation-sensitive restriction 
endonucleases, HpaII and MspI. HpaII cleaves 5’-CCGG-3’ 
sequences only if the internal C is unmethylated (27), whereas 
MspI cleaves 5’-CCGG-‘3 regardless of the methylation state 
of the internal C (28). Southern blotting revealed that normal 
colon tissue gave relatively larger HpaII fragments than either 
malignant or benign tumor tissue (Fig. 5A, compare lanes 1 
and 2 with lanes 3-6 or 9, respectively), in spite of the fact 
that the ethidium bromide-stained gels showed no detectable 
differences in HpaII sensitivity (not shown). Interestingly, 
DNA isolated from cultured colon carcinoma cells (Fig. 5A, 
lane 7) was resistant to HpaII in contrast to colon fibroblasts 
(Fig. 5A, lane 8) in which a major band of about 7 kb appeared. 
Restriction fragments generated by MspI (Fig. 5B) were 
essentially invariant among the tissues and cells examined. 
This indicates that the changes in HpaII restriction pattern 
shown in Fig. 5A were due to the presence of the modified 
base 5methylcytosine in the PG-40 gene. Specifically, six 
different DNA fragments of about 7, 5.5, 3.8, 2, 1.2, and 0.85 
kb were generated by MspI digestion. The first five fragments 
were detected in all the tissues examined, whereas the 0.85- 
kb fragment was present in about half of the specimens. These 
results are consistent with genetic polymorphism, rather than 
with gene rearrangements, since no differences were noted in 
the restriction fragments generated by other three enzymes 
(cf. Fig. 4). 
The degree of hypomethylation of PG-40 gene (Fig. 6A) 
was determined by calculating the absorbance ratio of the 
smaller HpaII fragments (group II, Fig. 5A) to the that of the 
total HpaII fragments (group I plus group 11, Fig. 5A). The 
Southern blots were also hybridized with human @-actin 
cDNA and the degree of hypomethylation calculated as above 
(Fig. 6B). The PG-40 gene from colon carcinoma (n = 8) was 
about three times more hypomethylated than normal colon 
(n = 5) (Fig. 6A), in contrast to that of /3-actin that showed 
no significant difference (Fig. 6B). Colon carcinoma cells 
exhibited the lowest degree of hypomethylation (Fig. 6A), 
consistent with the fact that colon carcinoma cells do not 
express this gene product (12) and do not show any immu- 
noreactivity with anti-PG-40 antibody both in vitro and in 
vivo (11). In contrast, human colon fibroblasts, which express 
this product (lo), showed a significant degree of hypometh- 
lamina propria and the submucosal connective tissue. F and G, sections of tumor tissue reacted with 2B6 monoclonal 
antibodies; note the marked reaction of the tumor stroma and the lack of reaction of the malignant epithelial cells 
(asterisk). H, colon carcinoma; I, normal colon reacted with 7D4 monoclonal antibody directed against native 
chondroitin sulfate; notice again the stromal labeling and the intensity in the tumor stroma. J, control section for 
7D4 antibody. K, cross-section of tumor tissue reacted with monospecific anti-peptide antiserum which recognizes 
the amino terminal peptide of PC-40; notice the stromal distribution similar to the chondroitin 4- and 6sulfate 
epitopes. L, control section for anti-PG-40 antibodies (A-L X 200). A summary of the immunostaining is provided 
in Table I. 
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1 ? 3 
FIG. 3. Analysis of RNA in normal human colon and colon 
carcinoma tissue. A, total amount of RNA. B, Northern blottings 
of 10 wg of total RNA isolated from skin fibroblast (lane I), and 5 fig 
each of poly (A’) RNA from colon carcinoma (lane 2) and normal 
colon (lane 3). The blots were reacted with a full-length cDNA 
encodmg PG.40 under high stringency as described in detail under 
“Experimental Procedures.” Notice the two transcripts of 1.9 and 1.6 
kb typical of PG.40 m both colon fibroblasts and colon tissues. 
Similar transcripts were observed m human colon smooth muscle 
cells but not m colon carcinoma cell RNA (not shown). Relative 
hybridization for PG.40 transcripts was determined by laserbeam 
scannmg densitometry of slot blots run m triplicate and expressed as 
absorbance umts/mg of RNA (C) or corrected for changes in total 
RNA content and expressed as absorbance units per gram of tissue 
(I)). When the data were expressed on d-actin hybridization, similar 
increases in PG-40 mRNA levels were obtained (not shown). 
ylation (Fig. 6A). Finally, DNA isolated from an adenomatous 
polyp exhibited a pattern of methylation similar to the malig- 
nant tissue (Fig. 6A), suggesting that hypomethylation is 
associated with connective tissue activation and remodelling 
occurring in neoplasia. Analysis of the data presented in Fig. 
6B clearly show that the PG-40 values would not significantly 
change if normalized to /3-actin hybridization values. 
In summary, these results indicate that the expression of 
PG-40 gene is activated in colon carcinoma tissue and provide 
a plausible explanation for the increased PG-40 mRNA levels 
and proteoglycan content in this tumor. 
DISCUSSION 
In this study we have used a variety of immunological and 
molecular biological approaches to investigate changes in the 
expression of chondroitin sulfate proteoglycan in human co- 
lon carcinoma. The results show a marked increase in a 
chondroitin sulfate proteoglycan with immunological and 
structural characteristics similar to the ubiquitous PG-40 
proteoglycan (18), also named “decorin” for its ability to bind 
and decorate collagen fibrils (7). The glycosaminoglycan com- 
position of tumor-associated proteoglycans appeared to be 
altered, displaying increased levels of 0- and 6-sulfate epitopes 
when compared with normal colon proteoglycans. The tumor 
distribution of this gene product was also quite striking since 
it localized predominantly to the newly formed connective 
FIG. 4. Southern blot hybridization analysis of genomic 
DNA from normal colon and colon carcinoma tissue with PG- 
40 (A) or c-src (B) cDNA. Twenty pg of genomic DNA isolated 
from normal colon (N) and tumor tissue (2’) was digested with various 
restriction endonucleases (PstI, Bg211, and HindIII) and reacted with 
“P-labeled PG.40 cDNA (A) or C-UC proto-oncogene cDNA (R). In 
B, lanes 1, 4, and 7 are samples digested with PstI; lanes 2, 5, and 8 
are samples digested with &III; and lanes 3, 6, and 9 are samples 
digested with HzndIII. The size in kilobase pairs of DNA markers is 
indicated at the margins. Notice the presence of DNA fragments of 
comparable intensity and pattern in both normal and tumor tissue, 
indicating no significant amplification or rearrangements of either of 
these two genes. 
I 2 3456789 123,56 7 x 9 
FIG. 5. Methylation patterns of PG-40 locus in normal hu- 
man colon, colon carcinoma tissue, benign colonic polyp, and 
cultured cells. Twenty pg of genomic DNA isolated from normal 
colon (N), colon carcinoma tissue (Z’), WiDr colon carcinoma cells 
(W), normal human colon fibroblasts (F), or benign adenomatous 
polyp of colon (P) were digested with HpaII (A) or MspI (B) restric- 
tion endonucleases and analyzed by Southern blotting using ‘“P- 
labeled PG-40 cDNA insert. The size in kilobase pairs of DNA 
markers is indicated in the margins. Notice the presence of relatively 
smaller fragments in the HpaII-digested DNA from the tumor tissue 
uis d uis the normal tissue. The ethidium bromide stained gel did not 
show any detectable change among any of the DNA samples (not 
shown). For additional details, see Fig. 6. 
 at UNIVERSITY O
F DEBRECEN, on Novem
ber 16, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
A I3 = Narmol Colon PC-40 
lm = colon Carcinema 
I = Polyp 
g100 SD -  Colon Carcinoma Cells 
c rZa = Colon Flbroblasto 
Altered Proteoglycan Expression in Colon Cancer 11395 
istics related to PG-40 are indeed the major source of these 
changes. We further show that the steady state levels of PG- 
40 mRNA were significantly elevated and that the total con- 
tent of this specific transcript was over seven times greater 
than that of normal tissue, whether the values were normal- 
ized to total RNA content or @actin mRNA levels. Because 
transformed colon epithelial cells do not express detectable 
levels of PG-40 mRNA nor express the proteoglycan in vitro 
(11, 12), the present results imply that connective tissue cells 
are stimulated to produce this gene product. Since our data 
are based on RNA extracted from whole tissue, it cannot be 
excluded that the changes in PG-40 mRNA levels are related 
to a greater number of connective tissue cells in the tumor. 
However, previous morphometric studies (8) have shown that 
the various cellular compartments of colon carcinoma tissue 
are not significantly different from the normal state. 
7s B 
t 
p-Actin 
FIG. 6. Quantitation of the degree of hypomethylation of 
PG-40 (A) and @-actin (Ii) genes in human colon tissue and 
cultured colon cells. The degree of PG-40 hypomethylation was 
obtained by calculating the absorbance ratio of group II (the smaller 
molecular -weight HpaII fragments as indicated in-Fig. 5A) to the 
total (group I plus group 10 HpaII fragments from several autoradi- 
ographs of Southern blots as described before (34). The proportion of 
II/I s II was determined for each digest and recorded as percent of 
hwomethvlation. The Southern blots were heated at 100 “C in 0.1% 
s&urn dodecyl sulfate, exposed overnight to check for complete 
removal of the probe, rehybridized with p-actin cDNA, and quanti- 
tated for methylation (B) as for the PG-40. The values for the normal 
colon (n = 5) and colon carcinoma (n = 8) represent the mean f SE. 
The values for the remaining samples are the mean of duplicate 
determinations. 
tissue surrounding the tumor cells. The presence of this 
nroteoglvcan within the tumor stroma was clearlv demarcated 
from the native connective tissue by using monoclonal anti- 
bodies directed against the intact glycosaminoglycan chains, 
against the major chondroitinase ABC-generated disaccharide 
epitopes, or against the amino terminal peptide of PG-40 
protein core. In contrast, in normal colon tissue, PG-40 pro- 
teoglycan was expressed at relatively lower levels, was pri- 
marily associated with blood vessels, and was only focally 
present in the interstitium. These findings corroborate our 
previous histochemical and autoradiographic studies which 
show a similar tissue distribution of chondroitin sulfate pro- 
teoglycans (8) and with our organ culture studies of human 
colon carcinoma which show enhanced synthesis of a small 
chondroitin sulfate proteoglycan by the tumor tissue (9). It is 
noteworthy that similar tumor-associated changes in connec- 
tive tissue composition are also observed in distant metastases 
of colon carcinoma (2, 32) and in a number of carcinomas 
(33) with mornhoeenetic features similar to colon cancer. but 
are absent in m&nant neoplasms that do not induce a 
stromal response (3). This argues that the neoplastic-associ- 
ated stromal changes are tumor-specific and not just an 
epiphenomenon, i.e. a nonspecific response of the host (see 
below). 
Using Southern blot hybridization, we demonstrate that 
PG-40 gene was neither significantly amplified nor rear- 
ranged. However, when we tested the degree of methylation 
of the PG-40 gene using methylation-sensitive and -insensi- 
tive restriction endonucleases, we found a 3-fold decrease in 
the methylation state of this gene in colon carcinoma tissue. 
The specificity of these findings was validated by analysis of 
B-actin methylation, a gene that was equally hypomethylated 
in normal and colon carcinoma tissue. The DNA of a variety 
of genes has been found to be undermethylated in cells and 
tissues where they are expressed and to be methylated when 
they are not expressed (29-31). Methylation of DNA is a 
covalent modification of the mammalian genome, with about 
70% of cytosine in CG sequences being methylated in normal 
cells (29-31). Recent studies have shown a nonrandom de- 
crease in DNA methylation of specific genes in various tumors 
including colon carcinoma (34-36). In the present study, the 
degree of hypomethylation was not a general phenomenon, 
since ethidium bromide-stained gels before Southern blotting 
revealed no significant differences in &a11 sensitivity be- 
tween normal and neoplastic colon. These data confirm pre- 
vious reports (34, 36), and further stress that specific genes 
show undermethylation when tested by Southern blotting, 
even in the absence of a general hypomethylation detectable 
with less sensitive methods. Our results are the first to dem- 
onstrate a hypomethylation in a gene encoding a ubiquitous 
proteoglycan and provide a plausible explanation for the 
increased PG-40 mRNA levels and proteoglycan content de- 
tected in this tumor. 
Because several genes are undermethylated to the same 
degree in both benign and malignant colonic neoplasms, it 
has been proposed that hypomethylation is a consistent DNA 
alteration of human colonic neoplasms and that this altera- 
tion precedes malignancy (36). Implicit in these studies, how- 
ever, is the concept that selective gene hypomethylation de- 
rives from the clonal neoplastic cells, whether benign or 
malignant, and no effort has been put on determining the 
cellular source of these alterations. In the present study, we 
have attempted to determine the cellular source of PG-40 
undermethylation by comparing DNA isolated from normal 
and transformed colon tissues with that of normal stromal or 
transformed epithelial cells derived from human colon. All 
the data point to a selective undermethylation of PG-40 in 
the neoplastic stromal cells, which correlates well with the 
immunohistochemical localization of PG-40, rather than in 
the neoplastic cells themselves. 
In the present studies we provide direct evidence that 
proteoglycans with immunological and structural character- 
An important question that needs to be addressed is about 
the specificity of these changes, that is, to what extent these 
DNA alterations are due to a nonspecific connective tissue 
response associated with neoplastic growth. In this context, 
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11396 Altered Proteoglycan Expression in Colon Cancer 
we have recently found’ in four different patients with ulcer- 
ative colitis, a chronic bowel disease characterized by active 
inflammation and tissue remodelling (l), that PG-40 gene is 
methylated to the same extent as normal colon. These results, 
together with PG-40 hypomethylation in a benign adenoma- 
tous polyp of the colon described in this report, suggest a 
significant degree of specificity for these DNA alterations and 
that these changes are associated with or induced by a clonal 
cell population. 
The finding of PG-40 hypomethylation in proliferating 
colon fibroblasts, but not in colon carcinoma cells, which do 
not express PG-40 (12), is further evidence for a connective 
tissue activation in response to tumor cytokines. This concept 
is based on the fact that analogous changes in chondroitin 
sulfate proteoglycan can be induced in vitro by either exposing 
colon fibroblasts to soluble cytokines released by the colon 
carcinoma cells (10) or by co-culturing colon carcinoma cells 
with colon fibroblasts or smooth muscle cells (11). An addi- 
tional regulatory mechanism could be provided by heparan 
sulfate proteoglycan. This proteoglycan binds a variety of 
growth factors (37), concentrates them in the extracellular 
matrix, and protects them from proteolytic attack (38, 39). 
Because colon carcinoma cells synthesize large amounts of 
heparan sulfate proteoglycan (12,40), and these levels can be 
further increased by exposing the cells to transforming growth 
factor @,3 it is conceivable that the enhanced expression of 
PG-40 may be in turn induced by growth factors bound to the 
heparan sulfate proteoglycan. 
In conclusion, we believe that modulation of extracellular 
matrix by neoplastic cells is an important step in tumor 
progression because it provides a proteoglycan-enriched well 
hydrated microenvironment which, by analogy with develop- 
mental systems, can favor the growth of tumor cells. Our 
results provide a molecular explanation for the previously 
reported proteoglycan changes in human colon carcinoma and 
raise the novel possibility that demethylating events associ- 
ated with or induced by a clonal cell population may affect 
specific connective tissue genes. 
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